JP2015519347A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015519347A5 JP2015519347A5 JP2015514191A JP2015514191A JP2015519347A5 JP 2015519347 A5 JP2015519347 A5 JP 2015519347A5 JP 2015514191 A JP2015514191 A JP 2015514191A JP 2015514191 A JP2015514191 A JP 2015514191A JP 2015519347 A5 JP2015519347 A5 JP 2015519347A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- receptor
- disorder
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261651961P | 2012-05-25 | 2012-05-25 | |
| US61/651,961 | 2012-05-25 | ||
| US201361789629P | 2013-03-15 | 2013-03-15 | |
| US61/789,629 | 2013-03-15 | ||
| PCT/US2013/042457 WO2013177418A1 (en) | 2012-05-25 | 2013-05-23 | Methods of regulating cannabinoid receptor activity-related disorders and diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015519347A JP2015519347A (ja) | 2015-07-09 |
| JP2015519347A5 true JP2015519347A5 (enExample) | 2016-09-29 |
| JP6130495B2 JP6130495B2 (ja) | 2017-05-17 |
Family
ID=48577922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015514191A Active JP6130495B2 (ja) | 2012-05-25 | 2013-05-23 | カンナビノイド受容体活性関連障害及び疾患を調節する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (5) | US20150157580A1 (enExample) |
| EP (1) | EP2854855B1 (enExample) |
| JP (1) | JP6130495B2 (enExample) |
| AU (1) | AU2013266235B2 (enExample) |
| CA (1) | CA2874655C (enExample) |
| WO (1) | WO2013177418A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3125878A4 (en) * | 2014-04-03 | 2017-11-29 | Mitchell Woods Pharmaceuticals, Inc. | Methods of treating breast cancer |
| WO2016144371A1 (en) * | 2015-03-06 | 2016-09-15 | Mitchell Woods Pharmaceuticals, Inc. | Methods of treating cancer |
| PE20181199A1 (es) * | 2015-09-30 | 2018-07-23 | Bird Rock Bio Inc | Anticuerpos que se unen al receptor cannabinoide 1 (cb1) humano |
| US20180271808A1 (en) * | 2015-10-01 | 2018-09-27 | Mitchell Woods Pharmaceuticals, Inc. | Methods of reducing chemoresistance and treating cancer |
| EP3684797A4 (en) * | 2017-09-19 | 2021-07-07 | Cannametrix, LLC | CELL BASED ASSAY FOR QUANTIFYING THE POWER AND EFFECTIVENESS OF CANNABINOIDS AND / OR TERPENOIDS, AND RELATED METHODS OF USE |
| WO2019207735A1 (ja) | 2018-04-26 | 2019-10-31 | Ｗｏｎｄｅｒ Ｖｉｓｉｏｎ Ｔｅｃｈｎｏ Ｌａｂｏｒａｔｏｒｙ株式会社 | ドーム状スクリーン、ドーム状スクリーン投影装置及びこれの組立て方法 |
| CN109942462B (zh) * | 2019-03-06 | 2022-01-14 | 宏冠生物药业有限公司 | 一种盐酸班布特罗的合成工艺 |
| JP7532754B2 (ja) * | 2019-09-04 | 2024-08-14 | 株式会社ニコン | 画像解析装置、細胞培養観察装置、画像解析方法、及びプログラム |
| GB202302225D0 (en) * | 2023-02-16 | 2023-04-05 | Atrogi Ab | New medical uses |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69325454T2 (de) | 1992-04-17 | 2000-01-20 | Abbott Laboratories, Abbott Park | Taxol-derivate |
| US5912264A (en) | 1997-03-03 | 1999-06-15 | Bristol-Myers Squibb Company | 6-halo-or nitrate-substituted paclitaxels |
| CO5280224A1 (es) | 2000-02-02 | 2003-05-30 | Univ Florida State Res Found | Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen |
| WO2004018478A2 (en) | 2002-08-23 | 2004-03-04 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| WO2004074844A1 (en) * | 2003-02-18 | 2004-09-02 | Astrazeneca Ab | Screening assays for cannabinoid-ligand-type modulators of gpr55 |
| EP2064174B1 (en) | 2006-08-10 | 2016-10-26 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Preparation of (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure |
| CN102740895B (zh) * | 2009-12-23 | 2016-02-24 | 伊利诺伊大学董事会 | 纳米轭合物以及纳米轭合物配制品 |
| JP5837890B2 (ja) * | 2010-03-10 | 2015-12-24 | アメリカ合衆国 | 神経膠芽腫および星状細胞腫の治療におけるフェノテロールおよびフェノテロール類似体の使用 |
-
2013
- 2013-05-23 EP EP13727753.9A patent/EP2854855B1/en active Active
- 2013-05-23 JP JP2015514191A patent/JP6130495B2/ja active Active
- 2013-05-23 AU AU2013266235A patent/AU2013266235B2/en active Active
- 2013-05-23 US US14/403,516 patent/US20150157580A1/en not_active Abandoned
- 2013-05-23 WO PCT/US2013/042457 patent/WO2013177418A1/en not_active Ceased
- 2013-05-23 CA CA2874655A patent/CA2874655C/en active Active
-
2016
- 2016-08-01 US US15/225,643 patent/US10130593B2/en active Active
-
2018
- 2018-09-12 US US16/129,569 patent/US10485771B2/en active Active
-
2019
- 2019-10-11 US US16/600,234 patent/US10772849B2/en active Active
-
2020
- 2020-08-13 US US16/992,742 patent/US11389415B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10166246B2 (en) | TGR5 agonist complexes for treating diabetes and cancer | |
| JP2019516711A5 (enExample) | ||
| JP2011057693A5 (enExample) | ||
| JP2014505008A5 (enExample) | ||
| JP2019501133A5 (enExample) | ||
| JP2013522230A5 (enExample) | ||
| JP2020502103A5 (enExample) | ||
| JP2019507781A5 (enExample) | ||
| RU2015143610A (ru) | Лечение катаплексии | |
| JP2013526544A5 (enExample) | ||
| JP2015511638A5 (enExample) | ||
| JP2014525464A (ja) | 置換ピラゾロ［３，４−ｄ］ピリミジンおよびその用途 | |
| JP2013509429A5 (enExample) | ||
| JP2015536964A5 (enExample) | ||
| JP2015508103A5 (enExample) | ||
| JP2016515628A5 (enExample) | ||
| JP2015536997A5 (enExample) | ||
| TWI462908B (zh) | 用於治療增生性失調症的化合物 | |
| JP2013509411A5 (enExample) | ||
| Peled et al. | Effective crizotinib schedule for brain metastases in ALK rearrangement metastatic non–small-cell lung cancer | |
| JP2014533272A5 (enExample) | ||
| JP2008535785A5 (enExample) | ||
| JP2019532047A5 (enExample) | ||
| JP2014512355A5 (enExample) | ||
| JP2014530181A5 (enExample) |